Literature DB >> 10419707

Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management.

Z E El Rassi1, C Partensky, J Y Scoazec, L Henry, C Lombard-Bohas, G Maddern.   

Abstract

AIMS: To report the clinical presentation, diagnosis and results of aggressive surgical management in patients with intrahepatic cholangiocarcinoma.
METHODS: From February 1988 to June 1998, 21 patients underwent laparotomy with a 90% resectability rate (19 resections). The 19 liver resections included right trisegmentectomy in six patients, right lobectomy in five, wedge resection in four, left lobectomy in two, left trisegmentectomy in one and a lateral segmentectomy in one. Resection of the biliary confluence with reconstruction by a Roux en Y hepaticojejunostomy was performed in three patients.
RESULTS: Mild abdominal pain, weight loss and gastrointestinal disturbances were the most frequent clinical signs. Jaundice was present in only four patients. Pre-operative radiological investigations (abdominal ultrasound, computed tomography, arteriography) correlated with pathological findings in only 60% of cases. Pre-operative histological findings (fine-needle cytology, liver biopsy), available for 19 patients, did not always provide an accurate diagnosis. The mortality and morbidity rates were 5 and 47%, respectively. The median survival of resected patients was 18 months. Overall patient and tumour-free survival rates were 83 and 31% at 1 year, 33 and 16.5% at 2 years and 16.5 and 16.5% at 3 years in the resected group. Lymph-node spread, vascular invasion, positive margins and bilobar distribution were associated with a high recurrence rate and poor prognosis.
CONCLUSION: Despite the advanced stage of these tumours at presentation, patient survival can be improved by aggressive surgical resection. As intrahepatic cholangiocarcinoma usually develops in a non-cirrhotic liver, major hepatic resections to obtain disease-free margins can be performed with low mortality. Copyright 1999 W.B. Saunders Company Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10419707     DOI: 10.1053/ejso.1999.0660

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  18 in total

1.  Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma.

Authors:  Yuji Morine; Mitsuo Shimada; Tohru Utsunomiya; Satoru Imura; Tetsuya Ikemoto; Jun Hanaka; Mami Kanamoto; Nobuhiro Kurita; Hidenori Miyake
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

2.  Intrahepatic Cholangiocarcinoma With Lymphoepithelioma-like Carcinoma Components Not Associated With Epstein-Barr Virus: Report of a Case.

Authors:  Suefumi Aosasa; Tadashi Maejima; Akifumi Kimura; Kiyoshi Nishiyama; Hiromi Edo; Hiroshi Shinmoto; Tatsumi Kaji; Sho Ogata; Kazuo Hatsuse; Kazuo Hase; Junji Yamamoto
Journal:  Int Surg       Date:  2015-04

3.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

4.  Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma.

Authors:  Shen Xiaohong; Li Huikai; Wang Feng; Zhang Ti; Cui Yunlong; Li Qiang
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

5.  The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?

Authors:  Sameer H Patel; David A Kooby; Charles A Staley; Juan M Sarmiento; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2011-07-26       Impact factor: 3.647

6.  Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.

Authors:  Shiro Miwa; Shinichi Miyagawa; Akira Kobayashi; Yasuhiko Akahane; Takenari Nakata; Motohiro Mihara; Kei Kusama; Junpei Soeda; Shinichiro Ogawa
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

7.  Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role.

Authors:  Hideki Nishio; Ernest Hidalgo; Zaed Z R Hamady; Kadiyala V Ravindra; Anil Kotru; Dowmitra Dasgupta; Ahmed Al-Mukhtar; K Rajendra Prasad; Giles J Toogood; J Peter A Lodge
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

8.  A case of distal extrahepatic cholangiocarcinoma with two positive resection margins.

Authors:  Wayne A Warner; Wesley Ramcharan; Dave Harnanan; Srikanth Umakanthan; Ravi Maharaj
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

Review 9.  Clinical diagnosis and staging of cholangiocarcinoma.

Authors:  Boris Blechacz; Mina Komuta; Tania Roskams; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-02       Impact factor: 46.802

10.  Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.

Authors:  Jiro Okami; Keizo Dono; Masato Sakon; Masanori Tsujie; Nobuyasu Hayashi; Yoshiyuki Fujiwara; Hiroaki Nagano; Koji Umeshita; Shoji Nakamori; Morito Monden
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.